Search results for "Ventricular Remodeling"

showing 10 items of 61 documents

The elite judo female athlete's heart.

2022

Purpose: There is a paucity of data on physiological heart adaptation in elite-level judo female athletes. This study aimed to assess left ventricular morphology and function in highly trained elite female judokas.Methods: The study prospectively included 18 females aged 23.5 ± 2.25 years, nine elite level judokas, and nine healthy non-athlete volunteers. All participants underwent a medical examination, electrocardiogram, and transthoracic 2D echocardiogram. Left ventricular diastolic and systolic diameters and volumes were determined, and parameters of left heart geometry and function (systolic and diastolic) were measured, calculated, and compared between groups.Results: When groups were…

left ventricular geometryPhysiologyPhysiology (medical)combat sportsechocardiographyventricular remodelingphysiological adaptationFrontiers in physiology
researchProduct

Decrease of CD4+ T Lymphocytes after myocardial infarction is related with extensive myocardial fibrosis

2013

Purpose: Myocardial fibrosis plays a potential role in left ventricular remodeling and patients' outcome. After myocardial infarction innate immune cells infiltrate infarcted area and replace necrotic tissue by fibrotic tissue. However the role of adaptive immunity, especially T cells, has not yet been investigated in this scenario. Methods: We studied 94 patients with a first STEMI treated with percutaneous revascularization. Leucocyte subsets and a wide variety of lymphocyte subtypes were determined in peripheral blood 24 h after reperfusion by means of flow cytometry. Infarct size and cardiac fibrosis were measured by late enhancement Cardiac Magnetic Resonance (CRM) 1 week and 6 months …

medicine.medical_specialtyCardiac fibrosisbusiness.industryLymphocyteInfarctionmedicine.diseaseAcquired immune systemmedicine.anatomical_structureImmune systemFibrosisInternal medicinecardiovascular systemmedicineCardiologyMyocardial fibrosisCardiology and Cardiovascular MedicineVentricular remodelingbusinessEuropean Heart Journal
researchProduct

EpCAM and microvascular obstruction in patients with STEMI: a cardiac magnetic resonance study

2021

Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): This study was funded by “Instituto de Salud Carlos III” and “Fondos Europeos de Desarrollo Regional FEDER” Bachground. Microvascular obstruction (MVO) is negatively associated with cardiac structure and worse prognosis after ST-segment elevation myocardial infarction (STEMI). Epithelial cell adhesion molecule (EpCAM), involved in endothelium adhesion, is an understudied area in the MVO setting. Purpose. We aimed to evaluate whether EpCAM is associated with the appearance of cardiac magnetic resonance (CMR)-derived MVO and long-term systolic function in reperfused STEMI. Methods.…

medicine.medical_specialtyEjection fractionEndotheliumbusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionInfarctionEpithelial cell adhesion moleculeGeneral Medicinemedicine.diseasechemistry.chemical_compoundmedicine.anatomical_structureReperfusion therapychemistryInternal medicineCardiologyMedicineRadiology Nuclear Medicine and imagingcardiovascular diseasesSystoleCardiology and Cardiovascular MedicinebusinessVentricular remodelingEuropean Heart Journal - Cardiovascular Imaging
researchProduct

P321Effect of biventricular pacing on ventricular remodeling in asymptomatic heart failure patients with ischemic cardiomyopathy

2018

medicine.medical_specialtyIschemic cardiomyopathybusiness.industrymedicine.diseaseAsymptomaticPhysiology (medical)Heart failureInternal medicineCardiologyMedicinemedicine.symptomCardiology and Cardiovascular MedicinebusinessVentricular remodelingEP Europace
researchProduct

Role of cardiac dyssynchrony and resynchronization therapy in functional mitral regurgitation

2016

Functional mitral regurgitation (FMR) is a common complication of left ventricle (LV) dysfunction and remodelling. Recently, it has been recognized as an independent prognostic factor in both ischaemic and non-ischaemic LV dysfunctions. In this review article, we discuss the mechanisms through which cardiac dyssynchrony is involved in FMR pathophysiologic cascade and how cardiac resynchronization therapy (CRT) can have therapeutic effects on FMR by reverting specific dyssynchrony pathways. We analyse recent clinical trials focusing on CRT impact on FMR in 'real-world' patients, the limits and future perspectives that could eventually generate new predictors of CRT response in terms of FMR r…

medicine.medical_specialtyPacemaker Artificialmedicine.medical_treatmentCardiac resynchronization therapyVentricular dyssynchrony030204 cardiovascular system & hematologyCardiac resynchronization; Mitral regurgitation; Ventricular dyssynchrony; Cardiology and Cardiovascular Medicine; Radiology Nuclear Medicine and ImagingVentricular Function LeftCardiac Resynchronization Therapy03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineInternal medicineCardiac resynchronizationNuclear Medicine and ImagingmedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineVentricular remodelingVentricular dyssynchronyMitral regurgitationMitral regurgitationClinical Trials as TopicVentricular Remodelingbusiness.industryCardiac Pacing ArtificialMitral Valve InsufficiencyStroke VolumeGeneral MedicineStroke volumemedicine.diseasePrognosisReview articleEchocardiography Doppler ColorClinical trialmedicine.anatomical_structureTreatment OutcomeVentriclecardiovascular systemCardiologyRadiologybusinessCardiology and Cardiovascular MedicineRadiology
researchProduct

Focus on right ventricular outflow tract septal pacing

2013

SummaryExperimental and clinical studies have shown that right ventricular apical pacing may result in long-term deleterious effects on account of its negative impact on left ventricular remodeling through desynchronization. This risk appears more pronounced in patients with even moderate left ventricular dysfunction and generally occurs after at least 1 year of pacing. As right ventricular apical pacing may be associated with the development of organic mitral insufficiency, other sites that allow for more physiological stimulation, such as right ventricular outflow tract septal pacing, have been developed, with good feasibility and reproducibility. However, the prospective randomized studi…

medicine.medical_specialtyPacemaker Artificialmedicine.medical_treatmentHeart VentriclesCardiac resynchronization therapyStimulation infundibulaireElectric CountershockVentricular SeptumMedium termCardiac Resynchronization TherapyDefibrillatorVentricular Dysfunction LeftInternal medicineMedicineVentricular outflow tractHumanscardiovascular diseasesDéfibrillateurCardiac Resynchronization Therapy DevicesVentricular remodelingHeart FailureStimulation septaleStimulation apicaleEjection fractionbusiness.industryHazard ratioCardiac Pacing ArtificialAtrial fibrillationStroke VolumeGeneral MedicineEquipment Designmedicine.diseaseDefibrillators ImplantablePacemakerTreatment OutcomeHomogeneousInfundibular pacingAnesthesiaCardiologycardiovascular systemVentricular Function RightSeptal pacingApical pacingbusinessCardiology and Cardiovascular MedicineArchives of Cardiovascular Diseases
researchProduct

Evaluating the quality of implantation of percutaneous ventricular restoration device (Parachute®) by cardiac computed tomography

2016

Background The Parachute is a novel percutaneously implanted ventricular partitioning device (VPD) that has emerged as a safe and feasible treatment option for patients with heart failure following anterior wall myocardial infarction. VPD efficacy is likely dependent on optimal device placement, but to date there are no published data examining the effect of device positioning on patient outcomes. Methods and results We retrospectively identified 32 patients successfully implanted with the Parachute device, all of whom underwent cardiac computed tomography (CCT) at baseline and after 6 months of follow-up. Patients were divided into two groups based on self-reported improvement in New York …

medicine.medical_specialtyPercutaneousbusiness.industrymedicine.medical_treatmentRetrospective cohort studyGeneral MedicineStroke volume030204 cardiovascular system & hematologymedicine.diseaseSurgery03 medical and health sciences0302 clinical medicineHeart failuremedicineRadiology Nuclear Medicine and imagingAnterior Wall Myocardial Infarction030212 general & internal medicineImplantCardiology and Cardiovascular MedicinebusinessVentricular remodelingCardiac catheterizationCatheterization and Cardiovascular Interventions
researchProduct

Special Article - Exercise-induced right ventricular injury or arrhythmogenic cardiomyopathy (ACM): The bright side and the dark side of the moon.

2020

There is still debate on the range of normal physiologic changes of the right ventricle or ventricular (RV) function in athletes. Genetic links to arrhythmogenic cardiomyopathy (ACM) are well-established. There is no current consensus on the importance of extensive exercise and exercise-induced injury to the RV. During the intensive exercise of endurance sports, the cardiac structures adapt to athletic load over time. Some athletes develop RV cardiomyopathy possibly caused by genetic predisposition, whilst others develop arrhythmias from the RV. Endurance sports lead to increased volume and pressure load in both ventricles and increased myocardial mass. The extent of volume increase and cha…

medicine.medical_specialtySports medicineVentricular Dysfunction RightCardiomyopathy030204 cardiovascular system & hematologyRisk AssessmentBoth ventriclesSudden cardiac death03 medical and health sciences0302 clinical medicineInternal medicinemedicineGenetic predispositionHumansGenetic Predisposition to Disease030212 general & internal medicineCardiomegaly Exercise-InducedPathologicalExerciseArrhythmogenic Right Ventricular DysplasiabiologyVentricular Remodelingbusiness.industryAthletesMyocardiummedicine.diseasebiology.organism_classificationAdaptation PhysiologicalFibrosismedicine.anatomical_structureDeath Sudden CardiacVentricleAthletesHeart Disease Risk FactorsCardiologyPhysical EnduranceVentricular Function RightCardiology and Cardiovascular MedicinebusinessProgress in cardiovascular diseases
researchProduct

Transplantation of Mesenchymal Stem Cells Exerts a Greater Long-Term Effect than Bone Marrow Mononuclear Cells in a Chronic Myocardial Infarction Mod…

2010

The aim of this study is to assess the long-term effect of mesenchymal stem cells (MSC) transplantation in a rat model of chronic myocardial infarction (MI) in comparison with the effect of bone marrow mononuclear cells (BM-MNC) transplant. Five weeks after induction of MI, rats were allocated to receive intramyocardial injection of 106 GFP-expressing cells (BM-MNC or MSC) or medium as control. Heart function (echocardiography and 18F-FDG-microPET) and histological studies were performed 3 months after transplantation and cell fate was analyzed along the experiment (1 and 2 weeks and 1 and 3 months). The main findings of this study were that both BM-derived populations, BM-MNC and MSC, ind…

medicine.medical_specialtyTime FactorsAngiogenesisMyocardial InfarctionBiomedical Engineeringlcsh:Medicine030204 cardiovascular system & hematologyMesenchymal Stem Cell TransplantationPeripheral blood mononuclear cellTimeRats Sprague-DawleyAndrology03 medical and health sciences0302 clinical medicineInternal medicinemedicineAnimalsRegenerationChronic myocardial infarctionCells CulturedCardiac remodelingBone Marrow Transplantation030304 developmental biologyStem cell transplantation for articular cartilage repair0303 health sciencesTransplantationBone marrow stem cellsVentricular Remodelingbusiness.industryMyocardiumlcsh:RMesenchymal stem cellBone Marrow Stem CellCell BiologyRatsEndothelial stem cellTransplantationDisease Models AnimalTreatment Outcomemedicine.anatomical_structureChronic DiseaseCardiologyFemaleAngiogenesisBone marrowbusinessCell Transplantation
researchProduct

Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Cas…

2020

Abstract Sacubitril/valsartan has been shown to reduce cardiovascular mortality and hospitalizations in patients with HFrEF when compared to enalapril. There are also some evidences of its potential antiarrhythmic effects. We present a report where we found a relation between reverse ventricular remodeling and arrhythmic reduction in a patient treated with sacubitril/valsartan.

medicine.medical_specialtymedicine.medical_treatmentARNIlcsh:Medicineheart failureCase ReportheartCase Reports030204 cardiovascular system & hematologySacubitril03 medical and health sciences0302 clinical medicineInternal medicinemedicineEnalaprilVentricular remodelingReverse remodelingarrhythmic burdenremodelinglcsh:R5-920business.industrylcsh:RGeneral Medicinemedicine.diseaseImplantable cardioverter-defibrillatorfailureValsartan030220 oncology & carcinogenesisHeart failureCardiologylcsh:Medicine (General)businessSacubitril Valsartanmedicine.drugClinical Case Reports
researchProduct